Division of Pathology, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.
Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, Tokyo, Japan.
J Appl Toxicol. 2020 Oct;40(10):1373-1383. doi: 10.1002/jat.3990. Epub 2020 May 5.
Compensation is a physiological response that occurs during chemical exposure to maintain homeostasis. Because compensatory responses are not usually considered adverse effects, it is important to understand compensatory mechanisms for chemical risk assessment. Although the kidney is a major target organ for toxicity, there is controversy over whether hyperplasia or hypertrophy contributes to the compensatory mechanism, and there is limited information to apply for chemical risk assessment. In the present study, compensatory mechanisms of the kidney were investigated in a unilateral nephrectomy (UNx) model using adult male and female F344 rats. In residual kidneys of male and female rats after UNx, 5-bromo-2'-deoxyuridine-labeling indices and mRNA expression of cell cycle-related genes were increased, although there were no fluctuations in mRNA expression of transforming growth factor-β1, which contributes to hypertrophy in renal tubules. Pathway analysis using mRNA expression data from a complementary DNA (cDNA) microarray revealed that canonical pathways related to cell proliferation were mainly activated and that forkhead box M1 (FOXM1) was an upstream regulator of compensatory cell proliferation in residual kidneys of male and female rats. cDNA microarray for microRNAs (miRNAs) demonstrated that nine miRNAs were downregulated in residual kidneys, and mRNA/miRNA integrated analysis indicated that miRNAs were associated with the expression of factors downstream of FOXM1. Overall, these results suggested that FOXM1-mediated hyperplasia rather than hypertrophy contributed to compensatory mechanisms in the kidney and that miRNAs regulated downstream FOXM1 signaling. These results will be beneficial for evaluating nephrotoxicity in chemical risk assessment and for developing new biomarkers to predict nephrotoxicity.
补偿是一种在化学暴露过程中发生的生理反应,旨在维持体内平衡。由于补偿反应通常不被视为不良反应,因此了解化学风险评估中的补偿机制非常重要。虽然肾脏是毒性的主要靶器官,但对于增生还是肥大有助于补偿机制存在争议,并且可用于化学风险评估的信息有限。在本研究中,使用成年雄性和雌性 F344 大鼠的单侧肾切除术 (UNx) 模型研究了肾脏的补偿机制。在 UNx 后雄性和雌性大鼠的残留肾脏中,5-溴-2'-脱氧尿苷标记指数和细胞周期相关基因的 mRNA 表达增加,尽管转化生长因子-β1 的 mRNA 表达没有波动,该因子有助于肾小管肥大。使用 cDNA 微阵列的 mRNA 表达数据进行的途径分析表明,与细胞增殖相关的典型途径主要被激活,叉头框 M1 (FOXM1) 是雄性和雌性大鼠残留肾脏中补偿性细胞增殖的上游调节剂。miRNA 的 cDNA 微阵列分析表明,有 9 个 miRNAs 在残留肾脏中下调,mRNA/miRNA 整合分析表明 miRNAs 与 FOXM1 下游因子的表达相关。总体而言,这些结果表明 FOXM1 介导的增生而不是肥大有助于肾脏的补偿机制,并且 miRNAs 调节下游的 FOXM1 信号。这些结果将有助于评估化学风险评估中的肾毒性,并开发预测肾毒性的新生物标志物。